| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |